Unexpected findings from a large Asian HCV real life study
Seong-In Lim, Nooh Abu Bakar(INTI International University), Mrunal Kamat, Khin Maung Win, Sonali Shah(Monash Health), Y.M. Lee, Hla Aung, Soek-Siam Tan(Hospital Selayang), Fakhar Ali Qazi Arisar, Shantanu Tyagi(All India Institute of Medical Sciences), Teerha Piratvisuth(Prince of Songkla University), K.P. Chen, Wasim Jafri(Aga Khan University Hospital), K.L. Goh, Shamila Hamid, Tawesak Tanwandee(Siriraj Hospital), Rahma Mohamed, Prashant Dhore, Abraham Koshy(Lakeshore Hospital), Wah Wah Phyo, Priya Abraham(Christian Medical College, Vellore), Rochak Mehta, K. Madan, CE Eapen, Wanxuan Yang, R.B.H.M. Said, Manav Wadhawan(BLK Super Speciality Hospital), Y.Y. Dan, Hoi Poh Tee, Tahir Ahmed, SHARON HO, Shahab Abid, Avvntikv Shukla, Tong Yin
Cited by 0
Related Papers
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
|Microorganisms|2021|658
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
|The Lancet|2021|361
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
|bioRxiv (Cold Spring Harbor Laboratory)|2021|268
Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
|Clinical Infectious Diseases|2018|256